ESC 365 - MicroRNA-mediated control of cardiac fibrosis: unraveling key players and mechanisms through functional genomics screenings

CBS PREMIUM ACCESS

MicroRNA-mediated control of cardiac fibrosis: unraveling key players and mechanisms through functional genomics screenings

Session: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

Topic: Fibrosis

Speaker: Doctor M. Mano (Coimbra, PT)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

About the speaker

Doctor Miguel Mano

CNC - Center for Neuroscience and Cell Biology, Coimbra (Portugal)

0 follower

3 more presentations in this session

Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen

Speaker: Assistant Professor V. Schwach (Enschede, NL)

The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy.

Speaker: Mr M. Panel (Montpellier, FR)

Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity

Speaker: Doctor T. Gergely (Budapest, HU)

Access the full session

Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

Speakers: Doctor M. Mano, Assistant Professor V. Schwach, Mr M. Panel, Doctor T. Gergely

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources